Companies › CLPT
CLEARPOINT NEURO INC (CLPT)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001285550 · EDGAR filings · Updated 2026-07-27
CLEARPOINT NEURO INC (CLPT) has reported institutional ownership of 43.8%, with 117 institutional managers holding positions valued at $118.3M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Filings this week (1)
- 2026-07-27 — SCHEDULE 13G/A filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-06 — Insider transaction reported (Form 4)
- 2026-07-06 — Insider transaction reported (Form 4)
- 2026-07-02 — Insider transaction reported (Form 4)
- 2026-07-02 — Insider transaction reported (Form 4)
- 2026-07-02 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, CLEARPOINT NEURO INC has 117 institutional holders and institutional ownership of 43.8%.
Insider activity
Insiders reported 73 transactions (0 buys, 11 sells) across 11 reporting insiders, with a net reported value of −$1.93M.
Data flags from SEC filings
Related companies
Whitehawk Therapeutics Inc (WHWK) · AGILON HEALTH INC (AGL) · THE ONCOLOGY INSTITUTE INC (TOI) · INOGEN INC (INGN) · AIRSCULPT TECHNOLOGIES INC (AIRS) · CYBIN INC (HELP)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.